Affinity Biosciences

Affinity Biosciences, established in 2006, is a leading life science and high-tech company whose biochemical products and services are mainly applied in biotechnology, medical research, and drug development. Since its inception, Affinity has been committed to providing researchers worldwide with the highest quality antibody products and services. To date, it has successfully developed over 14,000 antibodies and maintains a stock of more than 16,000 peptides. Phosphorylation antibodies are a hallmark product of the Affinity brand on the global stage. The company also offers fast and cost-effective custom antibody services, assisting numerous research institutions globally in achieving experimental goals and publishing their findings. Affinity antibodies are produced using peptide antigens combined with affinity purification, meeting the internationally recognized definition of monospecific antibodies. They employ one of the five validation strategies proposed by IWGAV—independent antibody validation—along with Affinity's unique blocking peptide + MS validation to ensure multiple levels of antibody quality control, guaranteeing optimal specificity and sensitivity for every antibody.